Screening compound: LAVHHMWKUVBWIF-UHFFFAOYSA-N

Screening compound: LAVHHMWKUVBWIF-UHFFFAOYSA-N
Screening compound: LAVHHMWKUVBWIF-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
LAVHHMWKUVBWIF-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-0684

Molecular Formula

C18H13NO3S2 (C18 H13 NO3 S2)

Compound Name

4-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}benzoic acid

IUPAC name

4-{[(5E)-3-benzyl-4-oxo-2-sulfanylidene-13-thiazolidin-5-ylidene]methyl}benzoic acid

SMILES

OC(c1ccc(/C=C(\C(N2Cc3ccccc3)=O)/SC2=S)cc1)=O

InChI

InChI=1S/C18H13NO3S2/c20-16-15(10-12-6-8-14(9-7-12)17(21)22)24-18(23)19(16)11-13-4-2-1-3-5-13/h1-10H,11H2,(H,21,22)

InChI Key

LAVHHMWKUVBWIF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02108918

LAVHHMWKUVBWIF-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Integrin Receptors Targeted library (1715 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Others
  • Nuclear receptors
  • Phosphatases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with LAVHHMWKUVBWIF-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound LAVHHMWKUVBWIF-UHFFFAOYSA-N?
Check Price and Availability of LAVHHMWKUVBWIF-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of LAVHHMWKUVBWIF-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for LAVHHMWKUVBWIF-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for LAVHHMWKUVBWIF-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of LAVHHMWKUVBWIF-UHFFFAOYSA-N available by request